CARR vs STRO
Carrier Global Corp (CARR) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CARR and STRO stock pages for the full models.
Not investment advice.